AtriCure (NASDAQ:ATRC – Free Report) had its price target boosted by Oppenheimer from $32.00 to $36.00 in a research report sent to investors on Wednesday, Benzinga reports. They currently have an outperform rating on the medical device company’s stock. Other equities research analysts have also issued research reports about the company. Piper Sandler dropped their […]

AtriCure (NASDAQ:ATRC – Free Report) had its price target increased by UBS Group from $35.00 to $40.00 in a report published on Wednesday, Benzinga reports. The firm currently has a buy rating on the medical device company’s stock. A number of other brokerages have also issued reports on ATRC. StockNews.com upgraded shares of AtriCure from […]

StockNews.com upgraded shares of Corning (NYSE:GLW – Free Report) from a hold rating to a buy rating in a report published on Thursday. GLW has been the topic of several other research reports. Citigroup boosted their price target on shares of Corning from $45.00 to $51.00 and gave the company a “buy” rating in a […]